Rhodiola: benefits, dosage, contraindications
Other name(s)
Rose gold
Scientific name(s)
Rhodiola rosea
Family or group:
Plants
Active ingredients:
Rosavins
Salidroside
Flavonoids
Beta-sitosterol
Indications
Rating methodology
EFSA approval.
Fatigue ✪✪✪✪✪
Preliminary clinical research shows that Rhodiola root extract may reduce fatigue in stressful situations. Most initial clinical trials assessed a specific extract (SHR-5®) at various doses across different populations ranging from 50 mg to 555 mg. This extract was standardized to contain 2.6% salidroside per tablet; or 2.3% salidroside, 0.4% p-tyrosol, and 2.7% rosavin per 144 mg tablet.
Posologie
Multicenter, Open-Label, Exploratory Clinical Trial With Rhodiola rosea Extract in Patients Suffering From Burnout Symptoms
The Effectiveness and Efficacy of Rhodiola Rosea L.: A Systematic Review of Randomized Clinical Trials
Therapeutic Effects and Safety of Rhodiola Rosea Extract WS® 1375 in Subjects With Life-Stress Symptoms--Results of an Open-Label Study
A Randomized Trial of Two Different Doses of a SHR-5 Rhodiola Rosea Extract Versus Placebo and Control of Capacity for Mental Work
Rhodiola Rosea in Subjects With Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial
Rhodiola Rosea (SHR-5), Part I: A Proprietary Root Extract of Rhodiola Rosea Is Found to Be Effective in the Treatment of Stress-Related Fatigue
Rhodiola rosea for mental and physical fatigue in nursing students: a randomized controlled trial.
The Influence of Adaptogens on Ultraweak Biophoton Emission: A Pilot-Experiment
Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty.
Acute Rhodiola rosea intake can improve endurance exercise performance.
A Double-Blind, Placebo-Controlled Pilot Study of the Stimulating and Adaptogenic Effect of Rhodiola Rosea SHR-5 Extract on the Fatigue of Students Caused by Stress During an Examination Period With a Repeated Low-Dose Regimen
The Effects of Rhodiola Rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms
Improve Adaptation Capacity ✪✪✪✪✪
The adaptogenic properties of Rhodiola demonstrate protection against stress, increased capacity for work and learning, and enhanced memory. A recent double-blind, placebo-controlled clinical study in young volunteers showed that taking standardized Rhodiola extracts increases endurance. The EMA recommends Rhodiola for the temporary relief of stress symptoms such as fatigue and feelings of weakness.
Posologie
Rhodiola rosea for mental and physical fatigue in nursing students: a randomized controlled trial.
A Double-Blind, Placebo-Controlled Pilot Study of the Stimulating and Adaptogenic Effect of Rhodiola Rosea SHR-5 Extract on the Fatigue of Students Caused by Stress During an Examination Period With a Repeated Low-Dose Regimen
The Influence of Adaptogens on Ultraweak Biophoton Emission: A Pilot-Experiment
Community herbal monograph on Rhodiola rosea L., rhizoma et radix
Cognitive Performance ✪✪✪✪✪
Rhodiola is suggested to promote attention and memory in stressful situations. It helps maintain focus during periods requiring high concentration and reduces feelings of fatigue.
Posologie
The Effects of Rhodiola Rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms
Therapeutic Effects and Safety of Rhodiola Rosea Extract WS® 1375 in Subjects With Life-Stress Symptoms--Results of an Open-Label Study
Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty.
A Double-Blind, Placebo-Controlled Pilot Study of the Stimulating and Adaptogenic Effect of Rhodiola Rosea SHR-5 Extract on the Fatigue of Students Caused by Stress During an Examination Period With a Repeated Low-Dose Regimen
The Effectiveness and Efficacy of Rhodiola Rosea L.: A Systematic Review of Randomized Clinical Trials
A Randomized Trial of Two Different Doses of a SHR-5 Rhodiola Rosea Extract Versus Placebo and Control of Capacity for Mental Work
Sports Performance ✪✪✪✪✪
Studies suggest that Rhodiola supplementation (standardized extract with 3% Rosavin and 1% Salidroside) improves athletic performance such as exhaustion, maximum oxygen uptake, execution time, and power.
Posologie
Effects of Chronic Rhodiola Rosea Supplementation on Sport Performance and Antioxidant Capacity in Trained Male: Preliminary Results
Acute Rhodiola rosea intake can improve endurance exercise performance.
The Effectiveness and Efficacy of Rhodiola Rosea L.: A Systematic Review of Randomized Clinical Trials
Rhodiola rosea does not reduce in vivo inflammatory activity after continuous endurance exercise
Anxiety ✪✪✪✪✪
Preliminary clinical research shows that taking a specific dry extract of Rhodiola at a dose of 200 mg twice daily for 14 days slightly reduces reported anxiety levels by 11% from baseline, as well as reported anger, confusion, negative mood, and stress levels in anxious students. Compared to a control group, these changes are significant.
Posologie
Depression ✪✪✪✪✪
Preliminary clinical research shows that taking a standardized Rhodiola extract (SHR-5®) at a dose of 340 mg once or twice daily reduces symptoms of mild to moderate depression after 6 weeks of treatment compared to placebo. Rhodiola reduced general depression symptoms, emotional instability, insomnia, and somatization.
Posologie
Rosenroot (Rhodiola Rosea): Traditional Use, Chemical Composition, Pharmacology and Clinical Efficacy
Rhodiola rosea L. as a putative botanical antidepressant
Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.
Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial
Stress ✪✪✪✪✪
Clinical studies have demonstrated a significant reduction in stress among patients treated with Rhodiola compared to a placebo.
Posologie
Healthy Aging ✪✪✪✪✪
Rhodiola could play an important role in brain health and overall well-being, particularly in the context of aging. Given its various neuroprotective properties, Rhodiola is of particular interest to older adults. Rhodiola has shown its ability to protect neurons against oxidative stress and cellular damage, two major factors in the development of neurodegenerative diseases such as Alzheimer's and Parkinson's. Additionally, Rhodiola is indicated in the management of cerebrovascular disorders in older individuals.
Posologie
Properties
Adaptogenic
The adaptogenic properties of Rhodiola show protection against stress, increased work capacity and learning, and memory. Animal studies have shown that chronic intake of Rhodiola extract, standardized to 3% rosavins and 1% salidroside, effectively inhibits behavioral and physiological changes induced by prolonged exposure to mild stressors. This action is comparable to that of fluoxetine, a medication commonly used to treat depression. The beneficial effects of Rhodiola, when administered in several doses, are mainly related to its action on the hypothalamic-pituitary-adrenal (HPA) axis, a central system in the body's stress response. A single dose of Rhodiola can be useful in situations requiring a rapid stress response, by acting on the sympathoadrenal system. Rhodiola begins to act within 30 minutes of administration and its stimulating effect can last between 4 and 6 hours. This rapid action is attributed to the plant's active compounds, salidroside and rosavins. These effects have been observed in humans, with a recent double-blind, placebo-controlled clinical study on young volunteers showing that standardized Rhodiola extracts increase endurance.
Usages associés
Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats
A Double-Blind, Placebo-Controlled Pilot Study of the Stimulating and Adaptogenic Effect of Rhodiola Rosea SHR-5 Extract on the Fatigue of Students Caused by Stress During an Examination Period With a Repeated Low-Dose Regimen
Antidepressant
The components of Rhodiola: rhodioloside, salidroside, and tyrosol are associated with its antidepressant activity. They inhibit the activity of monoamine oxidase A, an enzyme linked to a number of psychiatric disorders such as depression, aggression, and antisocial behavior. They would also stimulate cognitive functions such as memory and learning. However, the mechanism is not documented. The effect of Rhodiola was tested in a double-blind, placebo-controlled clinical study in patients with mild to moderate depression with recurrent episodes. Results indicate that after 6 weeks of treatment with Rhodiola extract, there is a significant improvement, particularly in global depression and insomnia.
Usages associés
Antioxidant
Rhodiola has antioxidant properties and protects cells against oxidative stress and aging, especially liver cells thanks to the action of salidroside. Its antioxidant effects are potentially superior to those of other adaptogens such as eleuthero.
Bioenergizing
Rhodiola extracts would increase ATP production in muscles, thereby promoting endurance in physical activity.
Usages associés
Hepatoprotector
Rhodiola produces a hepatoprotective effect manifested by normalizing the activity of aspartate-aminotransferase and alkaline phosphatase and returning urea and bilirubin levels to normal. Rhodiola also reduces the activity of alanine aminotransferase and glutathione-S-transferase in the plasma of rats in a toxic hepatic model.
Cardiovascular
Rhodiola extracts might prevent stress-induced cardiac damage by preventing the increase of cardiac catecholamines and cyclic AMP. In animals, administration of Rhodiola extract prevents the reduction of contractile force after exposure to cold. Another study shows a marked preventive effect on adrenaline and calcium chloride (CaCl2)-induced arrhythmias. Salidroside appears responsible for these effects.
Neurological
Rhodiola, and particularly one of its components called salidroside, has demonstrated neuroprotective effects in animal studies. Salidroside acts in a dose-dependent manner to protect brain cells against different types of damage. One of the main ways salidroside protects the brain is by fighting oxidative stress, a process that can damage cells and is involved in many neurodegenerative diseases. Salidroside prevents apoptosis, which is programmed cell death often triggered by excessive oxidative stress. It also inhibits the production of reactive oxygen species (ROS), which are harmful byproducts of cellular metabolism that can cause significant damage to cells. Other studies have shown that Rhodiola inhibits monoamine oxidase B activity and therefore offers protection against neurodegenerative diseases associated with this enzyme such as Alzheimer's and Parkinson's. In addition, salidroside helps restore the mitochondrial membrane potential, essential for proper cell function, and reduces the concentration of free calcium inside cells, a factor that can contribute to cellular damage if excessive. Thanks to these properties, salidroside from Rhodiola could play an important role in the prevention and treatment of diseases related to brain injuries, such as ischemic strokes and neurodegenerative diseases.
Usages associés
Cognitive function
A clinical study measured the effect of Rhodiola on the mental performance of young doctors. A significant increase in cognitive functions was observed in the group treated with Rhodiola. The beneficial effects of Rhodiola on mental performance may be partly explained by its anti-cholinesterase action. The anti-cholinesterase action is Rhodiola's ability to inhibit the activity of the enzyme cholinesterase. This enzyme is crucial in the functioning of the nervous system as it breaks down acetylcholine, an essential neurotransmitter involved in many functions, including memory, concentration, and the learning process. Its inhibition leads to an increased concentration of acetylcholine in the brain, potentially positively impacting cognitive functions.
Usages associés
Anti-ageing
Preliminary evidence from animal research suggests that rhodiola could increase lifespan by reducing oxidative stress. Moreover, salidroside, a constituent of rhodiola, protects human fibroblast cells from premature aging by modulating oxidative status.
Usages associés
Anxiolytic
In mice, Rhodiola extract produced significant anxiolytic effects.
Usages associés
Antiviral
Laboratory research suggests that salidroside possesses antiviral activities against coxsackievirus B3 (a human pathogen linked to cardiac arrhythmias and acute heart failure) in vitro and in vivo. Additionally, flavonols isolated from Rhodiola appear to have anti-influenza viral activity in vitro.
Anti-inflammatory
Rhodiola has anti-inflammatory properties by reducing C-reactive protein levels and inhibiting enzymes involved in the inflammation cascade.
Safety dosage
Adult from 18 years: 100 mg - 600 mg (standardized extract)
Rhodiola extracts are often standardized according to their rosavin and/or salidroside content, with the most common quantities being from 2.7% to 3% for rosavin and from 1% to 2.7% for salidroside. It is not recommended to exceed 800 mg of extract per day.
Interactions
Médicaments
Antidiabetic: moderate interaction
In vitro and in animals, Rhodiola extract can decrease blood glucose by inhibiting alpha-glucosidase (an enzyme involved in the final stage of sugar digestion). Theoretically, Rhodiola can have additive effects with antidiabetic medications and increase the risk of hypoglycemia.
Antihypertensive: moderate interaction
In vitro and in animals, Rhodiola extract inhibits angiotensin-converting enzyme (an enzyme that catalyzes the conversion of angiotensin I to angiotensin II, which is a potent vasoconstrictor) and can lower blood pressure. Theoretically, Rhodiola can have additive effects on antihypertensives and increase the risk of hypotension.
Cytochrome P450 substrates: moderate interaction
In vitro, Rhodiola inhibits cytochrome P450 3A4 (CYP3A4). Theoretically, using Rhodiola with drugs metabolized by CYP3A4 can increase the levels of these drugs and consequently increase the risk of adverse effects.
Escitalopram: moderate interaction
In a case report, a patient taking escitalopram (a selective serotonin reuptake inhibitor with antidepressant effects) with Rhodiola experienced tachyarrhythmia. Escitalopram is partially metabolized by cytochrome P450 3A4, which is inhibited by Rhodiola. Theoretically, concurrent use of escitalopram and Rhodiola can increase escitalopram levels and increase the risk of adverse effects.
Immunosuppressants: moderate interaction
In vitro and in animals, Rhodiola has immunostimulating effects. Theoretically, it can interfere with immunosuppressive treatment.
P-glycoprotein substrates: moderate interaction
In vitro research has shown that Rhodiola inhibits P-glycoprotein (a protein that acts as a pump capable of expelling, with ATP-provided energy, specific substrates that can be endogenous molecules or exogenous xenobiotic substances), thereby promoting the absorption of P-glycoprotein substrates and consequently increasing the risk of adverse effects of these drugs.
Precautions
Pregnant women: avoid
Avoid usage due to lack of reliable and sufficient information.
Autoimmune diseases: use with caution
Rhodiola may have immunostimulating effects. Theoretically, it may exacerbate autoimmune diseases such as multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis.
Type 2 diabetes: use with caution
Rhodiola appears to have alpha-glucosidase activity (an enzyme involved in the final stage of sugar digestion) and may decrease blood glucose levels. Dosage adjustments of antidiabetic medications may be required.
Hypotension: use with caution
Rhodiola extract may inhibit angiotensin-converting enzyme (an enzyme that catalyzes the conversion of angiotensin I to angiotensin II, which is a potent vasoconstrictor) and lower blood pressure. Theoretically, Rhodiola could increase the risk of hypotension in hypotensive patients.
Breastfeeding women: avoid
Avoid usage due to lack of reliable and sufficient information.
Children up to 18 years: avoid
The use in children and adolescents under 18 years of age has not been established due to the lack of adequate data.
Bipolar disorder: avoid
Avoid in bipolar individuals due to the risk of manic episodes associated with the antidepressant effects of Rhodiola.